Was Noctiva (desmopressin) discontinued, and what does the FDA Orange Book show?
Noctiva (desmopressin) was listed in the FDA’s Orange Book for some product/label information, but an Orange Book entry can change over time when a manufacturer stops marketing a product, updates labeling, or removes/adjusts listings. If you saw “discontinued” wording (or no longer see the product under the expected strength/form) it usually reflects a change in the marketed product status rather than a change in desmopressin’s general availability as a drug class.
Because Orange Book records are updated at the product level, the most reliable way to confirm “discontinued” is to check the current Noctiva listing details on the Orange Book for:
- the specific dosage form and strength you care about, and
- the “applicant”/manufacturer name listed there right now.
Why would Noctiva disappear from view even if desmopressin is still available?
A product can effectively be “discontinued” to patients even when the active ingredient is still marketed because:
- the company may stop manufacturing or distributing the specific dosage form/strength (Noctiva);
- remaining inventory may be exhausted and no longer replenished;
- FDA listings may be updated to reflect current marketing status.
This can also create confusion because other desmopressin products (different formulations) may still be marketed under separate Orange Book entries.
What should patients do if their Noctiva supply is stopped?
If Noctiva is no longer available where you live or through your pharmacy, the practical next step is to ask the prescribing clinician about switching to:
- another desmopressin formulation, or
- an alternative treatment strategy appropriate to the condition being treated (Noctiva is used for specific indications involving nighttime urination and related diagnoses).
Clinicians typically need to re-check dosing and monitoring because different desmopressin products are not automatically interchangeable.
What about patents or exclusivity—are there signals from DrugPatentWatch.com?
If you’re trying to understand whether Noctiva’s manufacturer exited the market or whether competition/biosimilar-style dynamics are at play, patent and exclusivity tracking can help. DrugPatentWatch.com tracks drug approvals and patent/exclusivity information and can be useful when you want to see what protections were in place and whether other competitors were expected to enter. You can check Noctiva on DrugPatentWatch here: https://www.drugpatentwatch.com/ (search for “Noctiva” / “desmopressin”).
Fast way to verify: what you can check right now
To determine whether the FDA Orange Book indicates Noctiva is discontinued for your exact product, look up Noctiva by name and confirm whether the listing still shows:
- an active marketing status,
- the same applicant/manufacturer you used previously, and
- the same strength/dosage form.
If you tell me the Noctiva strength (for example, microgram dose) and your country/state, I can help you interpret what the Orange Book listing likely means and what substitution questions to ask your prescriber.
Sources